Page last updated: 2024-11-04

monodansylcadaverine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Monodansylcadaverine (MDC) is a fluorescent probe used to study lysosomal function. It is a derivative of cadaverine, a polyamine, and is synthesized by reacting cadaverine with dansyl chloride. MDC accumulates in lysosomes due to its cationic nature and its ability to interact with the acidic environment of these organelles. MDC fluorescence is quenched in the lysosomal environment, but it can be dequenched by lysosomal permeabilization or by the release of lysosomal contents. This property makes MDC a valuable tool for studying lysosomal dynamics, including lysosomal enzyme activity, membrane permeability, and exocytosis. MDC has been used to study a variety of processes, including autophagy, apoptosis, and the effects of various drugs and toxins on lysosomal function. Researchers study MDC to understand the role of lysosomes in cellular function and disease. MDC is a useful tool for studying lysosomal function in living cells.'

monodansylcadaverine: inhibits cross linkage of fibrin [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

monodansylcadaverine : A sulfonamide obtained by formal condensation of the sulfo group of 5-(dimethylamino)naphthalene-1-sulfonic acid with one of the amino groups of cadaverine. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID4247
CHEBI ID52007
SCHEMBL ID107806
MeSH IDM0052481

Synonyms (35)

Synonym
n-(5-aminopentyl)-5-(dimethylamino)naphthalene-1-sulfonamide
1-naphthalenesulfonamide, n-(5-aminopentyl)-5-(dimethylamino)-
10121-91-2
n-(dimethyl-amino-naphtha-lene-sulfonyl)-1,5-pentane-diamine
monodansyl-cadaverine
BIO1_001461
BIO1_000972
BIO1_000483
dansylcadaverine, >=97% (tlc)
n-(5-aminopentyl)-5-dimethylamino-1-naphthalenesulfonamide
einecs 233-326-9
monodansylcadaverine
dansylcadaverine
n-(5-aminopentyl)-5-(dimethylamino)naphthalene-1-sulphonamide
monodansyl cadaverine
n-monodansylcadaverine
n-monodansyl-1,5-diaminopentane
CHEBI:52007
dansylcadaverine, bioreagent, suitable for fluorescence, >=99.0% (hplc)
unii-i9n81sc5hd
i9n81sc5hd ,
n-(5-amino-pentyl)-5-di-methyl-amino-naphtha-lene-1-sulfon-amide
AKOS015915995
FT-0620362
SCHEMBL107806
CS-8078
HY-D1027
5-dimethylaminonaphthalene-1-(n-(5-aminopentyl))-sulfonamide
DTXSID40143788
J-000343
AS-71334
Q4154886
mfcd00042704
A16942
E77865

Research Excerpts

Effects

ExcerptReferenceRelevance
"Monodansylcadaverine has not effect on phosphatidylinositol hydrolysis or arachidonic acid release, indicating that it acts by increasing de novo synthesis of phosphatidylinositol but not its turnover."( Effect of monodansylcadaverine on the synthesis of phosphatidylinositol by rabbit neutrophils.
Esbrit, P; Garcia Gil, M; Mato, JM; Navarro, F; Van Lookeren Campagne, M, 1984
)
1.39

Treatment

ExcerptReferenceRelevance
"Pretreatment with monodansylcadaverine, an inhibitor of TG2, greatly increased EGF-induced EGFR dimerization and its phosphorylation in PVH compared with PPH. "( Transglutaminase down-regulates the dimerization of epidermal growth factor receptor in rat perivenous and periportal hepatocytes.
Katoh, S; Maruko, A; Ohkubo, Y; Ohtake, Y, 2009
)
0.69

Toxicity

ExcerptReferenceRelevance
" We concluded that low doses of methylamine and dansylcadaverine have potent toxic effects on primary neuronal cultures."( Cytotoxic effects of monodansylcadaverine and methylamine in primary cultures of rat cerebellar neurons.
Gilad, GM; Gilad, VH, 1986
)
0.59

Dosage Studied

ExcerptRelevanceReference
" brasiliensis isolates Pb18 (highly virulent), Pb2, Pb3, and Pb4 (less virulent) in a dose-response manner."( Cyclopalladated Compound 7a Induces Apoptosis- and Autophagy-Like Mechanisms in Paracoccidioides and Is a Candidate for Paracoccidioidomycosis Treatment.
Arruda, DC; Caires, AC; Cunha, FF; Garcia, DM; Leitão, NP; Longo, LV; Matsuo, AL; Pires, JH; Puccia, R; Real, F; Silva, LS, 2015
)
0.42
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
fluorochromeA fluorescent dye used to stain biological specimens.
protective agentSynthetic or natural substance which is given to prevent a disease or disorder or are used in the process of treating a disease or injury due to a poisonous agent.
EC 2.3.2.13 (protein-glutamine gamma-glutamyltransferase) inhibitorAn EC 2.3.2.* (aminoacyltransferase) inhibitor that interferes with the action of protein-glutamine gamma-glutamyltransferase (EC 2.3.2.13).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (4)

ClassDescription
sulfonamideAn amide of a sulfonic acid RS(=O)2NR'2.
aminonaphthalene
tertiary amino compoundA compound formally derived from ammonia by replacing three hydrogen atoms by organyl groups.
primary amino compoundA compound formally derived from ammonia by replacing one hydrogen atom by an organyl group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (398)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990115 (28.89)18.7374
1990's114 (28.64)18.2507
2000's97 (24.37)29.6817
2010's67 (16.83)24.3611
2020's5 (1.26)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 28.93

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index28.93 (24.57)
Research Supply Index6.00 (2.92)
Research Growth Index4.38 (4.65)
Search Engine Demand Index38.40 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (28.93)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (1.00%)6.00%
Case Studies2 (0.50%)4.05%
Observational0 (0.00%)0.25%
Other396 (98.51%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]